To gain a more comprehensive understanding of this mechanism, future research will utilize immunohistochemistry (IHC) and in situ hybridization (ISH) to examine CHI3L1 expression across various cell types within tumor tissue sections. This evidence concerns the gene CHI3L1 and neoplasm.